Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Quench Bio
400 Technology Square, 10th Floor
Cambridge, MA 02139
https://quenchbio.com/

Quench Bio is a biotechnology company leveraging new insights into gasdermin biology and innate immunity to develop medicines for severe inflammatory diseases. Quench's lead compounds target and inhibit the pore-forming protein Gasdermin D, a central player in both pyroptosis and NETosis pathways that mediates the release of inflammatory cytokines, alarmins, DNA and NETs. Quench Bio launched in January 2020 with $50 million from leading life science investors including Atlas Venture, Arix Bioscience, RA Capital and AbbVie Ventures.

Key Contact
Name
Samantha Truex
Title
CEO
Funding Events

Date
Amount
Type
Investors
01/27/20 $50,000,000 Series A AbbVie Biotech Ventures
Arix Bioscience
Atlas Venture
RA Capital Management